Needle Free Injections Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Summary
GlobalData's Medical Devices sector report, “Needle Free Injections Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Needle Free Injections pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Needle-free Injections are the devices that do not use a needle to administer medication.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Needle Free Injections under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Needle Free Injections and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Needle Free Injections under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
Introduction
Needle Free Injections Overview
Products under Development
Needle Free Injections - Pipeline Products by Stage of Development
Table Needle Free Injections - Pipeline Products by Stage of Development
Table Needle Free Injections - Pipeline Products by Stage of Development
Needle Free Injections - Pipeline Products by Territory
Table Needle Free Injections - Pipeline Products by Territory
Table Needle Free Injections - Pipeline Products by Territory
Needle Free Injections - Pipeline Products by Regulatory Path
Table Needle Free Injections - Pipeline Products by Regulatory Path
Table Needle Free Injections - Pipeline Products by Regulatory Path
Needle Free Injections - Pipeline Products by Estimated Approval Date
Table Needle Free Injections - Pipeline Products by Estimated Approval Date
Table Needle Free Injections - Pipeline Products by Estimated Approval Date
Needle Free Injections - Pipeline Products under Development by Companies
Needle Free Injections Companies - Pipeline Products by Stage of Development
Table Needle Free Injections Companies - Pipeline Products by Stage of Development
Needle Free Injections - Pipeline Products by Stage of Development
Table Needle Free Injections - Pipeline Products by Stage of Development
Needle Free Injections Companies and Product Overview
Table MicroDose Needlefree System - Product Status
Table MicroDose Needlefree System - Product Description
Needle Free Injections- Recent Developments
Jun 27, 2024: PharmaJet Needle-free System Selected for WHO Polio Immunization Campaign in Somalia
Jun 13, 2024: Chromadex to Launch Niagen+, the First-Of-Its-Kind Pharmaceutical-Grade Intravenous and Injectable Niagen (Patented Nicotinamide Riboside Chloride or Nrc)
May 30, 2024: Crossject Announces Publication of Clinical Data on Zepizure in Neurology and Therapy
May 08, 2024: Merck to Participate in the Bank of America Securities 2024 Healthcare Conference
May 08, 2024: Teva Pharmaceutical Industries Reports Earnings Results for the First Quarter Ended March 31, 2024
May 07, 2024: Baxter to Present at Bank of America 2024 Health Care Conference
May 02, 2024: Crossject signs a geographic extension of ZEPIZURE commercialization agreement in Europe